Back to MAbs for Pfizer as Dimebon reaches the end of the road in Alzheimer's
18 January 2012
Daniel Chancellor
Please Login to read the full article.
18 January 2012
Daniel Chancellor
dchancellor@datamonitor.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pharmos seeks gout bandwagon partner in last-chance saloon
- Intellect's early-stage anti-Tau vaccine for Alzheimer's could be first prophylactic
- Lurasidone on track for US bipolar filing following positive top-line PhIII results
- AstraZeneca dumps Targacept's antidepressant TC-5214 after two more Ph III failures
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
